Lymphoblastic Leukemia Overview
Lymphoblastic leukemia (ALL) is a type of blood cancer that affects the white blood cells known as lymphocytes. It is the most common form of leukemia among children and accounts for one-third of all leukemias diagnosed in adults. ALL develops when the body produces too many white blood cells, which can crowd out healthy cells and cause life-threatening infections, anemia, and other complications.
Survival Rate
The long-term survival rate of patients with ALL varies depending on age, gender, and the type and severity of the disease. In general, younger patients and those with a less aggressive form of the disease have a better prognosis. According to the American Cancer Society, the five-year survival rate for adults with ALL is around 63%, while the five-year survival rate for children is around 87%.
Treatment and Outlook
Treatment for ALL typically includes chemotherapy, radiation therapy, and stem cell transplants. Treatment is most successful when the disease is caught early. The outlook for those with ALL is much improved with modern treatments, and many patients can expect to live long and healthy lives.